The long-term efficacy of plasma-derived hepatitis B vaccine in babies born to carrier mothers.

Abstract

The long-term efficacy of a childhood hepatitis B vaccination programme was evaluated. A total of 112 newborn babies of hepatitis B carrier mothers were given hepatitis B immune globulin (HBIG) and a 10-microg three-dose regimen of plasma-derived vaccine administered at a conventional (0, 1, 6 months), delayed (2, 3, 8 months) or accelerated (0, 1, 2 months… (More)

Topics

Cite this paper

@article{Young2003TheLE, title={The long-term efficacy of plasma-derived hepatitis B vaccine in babies born to carrier mothers.}, author={B W Y Young and S. S. Lee and W L Lim and Eng-kiong Yeoh}, journal={Journal of viral hepatitis}, year={2003}, volume={10 1}, pages={23-30} }